The investment round was jointly spearheaded by Qiming Venture Partners USA and Versant Ventures. It also saw contributions from SV Health Investors, the company’s founding investor, and new The post Dualitas secures $65m for bispecific antibody pipeline appeared first on Pharmaceutical Business review.